{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T11:25:25Z","timestamp":1772105125794,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11060-025-05407-0","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:59:27Z","timestamp":1769525967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic significance of H3.K27me3 loss in CNS WHO grade 2 meningiomas: a multicentre clinicopathological study"],"prefix":"10.1007","volume":"176","author":[{"given":"Filippo","family":"Nozzoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"Ortenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Bonaudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Muscas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Cantarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Montemurro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Visani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Greto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Livi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Della Puppa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe Nicol\u00f2","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Giuseppe","family":"Naccarato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isacco","family":"Desideri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"1","key":"5407_CR1","doi-asserted-by":"publisher","first-page":"vdad004","DOI":"10.1093\/noajnl\/vdad004","volume":"5","author":"RA Vaubel","year":"2023","unstructured":"Vaubel RA, Kumar R, Weiskittel TM et al (2023) Genomic markers of recurrence risk in atypical meningioma following gross total resection. Neuro Oncol Adv 5(1):vdad004. https:\/\/doi.org\/10.1093\/noajnl\/vdad004","journal-title":"Neuro Oncol Adv"},{"issue":"1","key":"5407_CR2","doi-asserted-by":"publisher","first-page":"vdae002","DOI":"10.1093\/noajnl\/vdae002","volume":"6","author":"K Tosefsky","year":"2024","unstructured":"Tosefsky K, Martin KC, Rebchuk AD et al (2024) Molecular prognostication in grade 3 meningiomas and p16\/MTAP immunohistochemistry for predicting CDKN2A\/B status. Neuro Oncol Adv 6(1):vdae002. https:\/\/doi.org\/10.1093\/noajnl\/vdae002","journal-title":"Neuro Oncol Adv"},{"issue":"3","key":"5407_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0090-3019(86)90233-8","volume":"25","author":"J J\u00e4\u00e4skel\u00e4inen","year":"1986","unstructured":"J\u00e4\u00e4skel\u00e4inen J, Haltia M, Servo A (1986) Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25(3):233\u2013242. https:\/\/doi.org\/10.1016\/0090-3019(86)90233-8","journal-title":"Surg Neurol"},{"issue":"9","key":"5407_CR4","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/S1470-2045(17)30155-9","volume":"53","author":"F Nassiri","year":"2021","unstructured":"Nassiri F, Liu J, Patil V et al (2021) DNA methylation profiling defines clinically relevant genomic clusters in meningioma. Nat Genet 53(9):1325\u20131336. https:\/\/doi.org\/10.1016\/S1470-2045(17)30155-9","journal-title":"Nat Genet"},{"issue":"2","key":"5407_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/neuonc\/noae170","volume":"27","author":"F Sahm","year":"2025","unstructured":"Sahm F, Aldape KD, Brastianos PK et al (2025) cIMPACT-NOW update 8: clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas. Neuro Oncol 27(2):319\u2013330. https:\/\/doi.org\/10.1093\/neuonc\/noae170","journal-title":"Neuro Oncol"},{"issue":"6","key":"5407_CR6","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00401-018-1844-9","volume":"135","author":"LM Katz","year":"2018","unstructured":"Katz LM, Hielscher T, Liechty B et al (2018) Loss of histone H3 K27 trimethylation identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol 135(6):955\u2013963. https:\/\/doi.org\/10.1007\/s00401-018-1844-9","journal-title":"Acta Neuropathol"},{"issue":"8","key":"5407_CR7","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/neuonc\/noaa303","volume":"23","author":"F Behling","year":"2021","unstructured":"Behling F, Fodi C, Gepfner-Tuma I et al (2021) H3K27me3 loss indicates an increased risk of recurrence in the T\u00fcbingen meningioma cohort. Neuro Oncol 23(8):1273\u20131281. https:\/\/doi.org\/10.1093\/neuonc\/noaa303","journal-title":"Neuro Oncol"},{"key":"5407_CR8","doi-asserted-by":"publisher","first-page":"911524","DOI":"10.3389\/fonc.2022.911524","volume":"12","author":"J Lu","year":"2022","unstructured":"Lu J, Zhang Y, Xu T et al (2022) Prognostic significance of H3K27me3 loss in meningiomas: a systematic review and meta-analysis. Front Oncol 12:911524. https:\/\/doi.org\/10.3389\/fonc.2022.911524","journal-title":"Front Oncol"},{"issue":"3","key":"5407_CR9","first-page":"463","volume":"144","author":"AD Maier","year":"2022","unstructured":"Maier AD, Spiegl-Kreinecker S, Hervey-Jumper SL et al (2022) Histone H3K27me3 loss distinguishes biologically aggressive meningiomas independent of WHO grade. Acta Neuropathol 144(3):463\u2013474","journal-title":"Acta Neuropathol"},{"issue":"11","key":"5407_CR10","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.3390\/cancers15112945","volume":"15","author":"E Marastoni","year":"2023","unstructured":"Marastoni E, Barresi V (2023) Meningioma grading beyond histopathology: relevance of epigenetic and genetic features to predict clinical outcome. Cancers (Basel) 15(11):2945. https:\/\/doi.org\/10.3390\/cancers15112945","journal-title":"Cancers (Basel)"},{"issue":"7","key":"5407_CR11","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.3390\/cancers14071718","volume":"14","author":"S Ammendola","year":"2022","unstructured":"Ammendola S, Rizzo PC, Longhi M et al (2022) The immunohistochemical loss of H3K27me3 in intracranial meningiomas predicts shorter Progression-Free survival after stereotactic radiosurgery. Cancers (Basel) 14(7):1718. https:\/\/doi.org\/10.3390\/cancers14071718","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5407_CR12","doi-asserted-by":"publisher","first-page":"vdad112","DOI":"10.1093\/noajnl\/vdad112","volume":"5","author":"F Behling","year":"2023","unstructured":"Behling F, Pa\u00dflack P, Fodi CK et al (2023) Loss of H3K27me3 in meningiomas: an independent marker for CNS WHO grade 2? Neurooncol Adv 5(1):vdad112. https:\/\/doi.org\/10.1093\/noajnl\/vdad112","journal-title":"Neurooncol Adv"},{"issue":"4","key":"5407_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s10014-021-00422-0","volume":"38","author":"TY Jung","year":"2021","unstructured":"Jung TY, Jung S, Kim IY et al (2021) Clinical relevance of histone modification markers in meningiomas. Brain Tumor Pathol 38(4):266\u2013275. https:\/\/doi.org\/10.1007\/s10014-021-00422-0","journal-title":"Brain Tumor Pathol"},{"issue":"5","key":"5407_CR14","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00428-021-03134-1","volume":"479","author":"S Ammendola","year":"2021","unstructured":"Ammendola S, Caldonazzi N, Simbolo M et al (2021) H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphology. Virchows Arch 479(5):987\u2013996. https:\/\/doi.org\/10.1007\/s00428-021-03134-1","journal-title":"Virchows Arch"},{"issue":"1","key":"5407_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/neuonc\/noz162","volume":"21","author":"RY Huang","year":"2019","unstructured":"Huang RY, Bi WL, Weller M et al (2019) Proposed response assessment and endpoints for meningioma clinical trials: report from the response assessment in Neuro-Oncology working group. Neuro Oncol 21(1):26\u201336. https:\/\/doi.org\/10.1093\/neuonc\/noz162","journal-title":"Neuro Oncol"},{"issue":"3","key":"5407_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s11060-024-04572-y","volume":"166","author":"C Mirian","year":"2024","unstructured":"Mirian C, Jensen LR, Juratli TA et al (2024) The importance of considering competing risks in recurrence analysis of intracranial meningioma. J Neurooncol 166(3):503\u2013511. https:\/\/doi.org\/10.1007\/s11060-024-04572-y","journal-title":"J Neurooncol"},{"issue":"8","key":"5407_CR17","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/neuonc\/noab036","volume":"23","author":"F Nassiri","year":"2021","unstructured":"Nassiri F, Wang JZ, Singh O et al (2021) Loss of H3K27me3 in meningiomas. Neuro Oncol 23(8):1282\u20131291. https:\/\/doi.org\/10.1093\/neuonc\/noab036","journal-title":"Neuro Oncol"},{"issue":"1","key":"5407_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s40478-023-01615-9","volume":"11","author":"G Cello","year":"2023","unstructured":"Cello G, Patel RV, McMahon JT et al (2023) Impact of H3K27 trimethylation loss in meningiomas: a meta-analysis. Acta Neuropathol Commun 11(1):122. https:\/\/doi.org\/10.1186\/s40478-023-01615-9","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"5407_CR19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41392-022-01211-8","volume":"7","author":"K Wang","year":"2022","unstructured":"Wang K, Liu H, Hu Q et al (2022) Epigenetic regulation of aging: implications for interventions of aging and diseases. Signal Transduct Target Ther 7(1):374. https:\/\/doi.org\/10.1038\/s41392-022-01211-8","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"5407_CR20","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","volume":"18","author":"F Sahm","year":"2017","unstructured":"Sahm F, Schrimpf D, Stichel D et al (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18(5):682\u2013694. https:\/\/doi.org\/10.1016\/S1470-2045(17)30155-9","journal-title":"Lancet Oncol"},{"issue":"5","key":"5407_CR21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/neuonc\/noab213","volume":"24","author":"J Driver","year":"2022","unstructured":"Driver J, Hoffman SE, Tavakol S et al (2022) A molecularly integrated grade for meningioma. Neuro Oncol 24(5):796\u2013808. https:\/\/doi.org\/10.1093\/neuonc\/noab213","journal-title":"Neuro Oncol"},{"issue":"5","key":"5407_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41588-022-01061-8","volume":"54","author":"A Choudhury","year":"2022","unstructured":"Choudhury A, Magill ST, Eaton CD et al (2022) Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet 54(5):649\u2013659. https:\/\/doi.org\/10.1038\/s41588-022-01061-8","journal-title":"Nat Genet"},{"issue":"34","key":"5407_CR23","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1200\/JCO.21.00784","volume":"39","author":"SLN Maas","year":"2021","unstructured":"Maas SLN, Stichel D, Hielscher T et al (2021) Integrated Molecular-Morphologic meningioma classification: A multicenter retrospective Analysis, retrospectively and prospectively validated. J Clin Oncol 39(34):3839\u20133852. https:\/\/doi.org\/10.1200\/JCO.21.00784","journal-title":"J Clin Oncol"},{"key":"5407_CR24","doi-asserted-by":"publisher","first-page":"787962","DOI":"10.3389\/fonc.2021.787962","volume":"11","author":"D Song","year":"2021","unstructured":"Song D, Xu D, Han H et al (2021) Postoperative adjuvant radiotherapy in atypical meningioma patients: A Meta-Analysis study. Front Oncol 11:787962. https:\/\/doi.org\/10.3389\/fonc.2021.787962","journal-title":"Front Oncol"},{"issue":"2","key":"5407_CR25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11060-022-04169-3","volume":"161","author":"L Hua","year":"2023","unstructured":"Hua L, Ren L, Wu Q et al (2023) Loss of H3K27me3 expression enriches in recurrent grade 1&2 meningiomas and maintains as a biomarker stratifying progression risk. J Neurooncol 161(2):267\u2013275. https:\/\/doi.org\/10.1007\/s11060-022-04169-3","journal-title":"J Neurooncol"},{"issue":"7","key":"5407_CR26","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/jnen\/nlaa038","volume":"79","author":"G Gauchotte","year":"2020","unstructured":"Gauchotte G, Peyre M, Pouget C et al (2020) Prognostic value of histopathological features and loss of H3K27me3 Immunolabeling in anaplastic meningioma: A multicenter retrospective study. J Neuropathol Exp Neurol 79(7):754\u2013762. https:\/\/doi.org\/10.1093\/jnen\/nlaa038","journal-title":"J Neuropathol Exp Neurol"},{"key":"5407_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.humpath.2021.06.005","volume":"115","author":"M Jung","year":"2021","unstructured":"Jung M, Kim SI, Lim KY et al (2021) The substantial loss of H3K27me3 can stratify risk in grade 2, but not in grade 3 meningioma. Hum Pathol 115:96\u2013103. https:\/\/doi.org\/10.1016\/j.humpath.2021.06.005","journal-title":"Hum Pathol"},{"issue":"1","key":"5407_CR28","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/s41467-019-09624-w","volume":"10","author":"E Lavarone","year":"2019","unstructured":"Lavarone E, Barbieri CM, Pasini D (2019) Dissecting the role of H3K27 acetylation and methylation in PRC2 mediated control of cellular identity. Nat Commun 10(1):1679. https:\/\/doi.org\/10.1038\/s41467-019-09624-w","journal-title":"Nat Commun"},{"key":"5407_CR29","doi-asserted-by":"publisher","first-page":"123514","DOI":"10.1016\/j.wneu.2024.11.097","volume":"194","author":"S Deshpande","year":"2025","unstructured":"Deshpande S, Nayal B, Nair R et al (2025) Role of H3K27me3 and Ki-67 labeling index in assessing the biological behavior of meningiomas. World Neurosurg 194:123514. https:\/\/doi.org\/10.1016\/j.wneu.2024.11.097","journal-title":"World Neurosurg"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05407-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05407-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05407-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T10:47:47Z","timestamp":1772102867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05407-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["5407"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05407-0","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Local Ethics Committee of Tuscany (protocol number: 27080_BIO) and it was performed in accordance with the principles of the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}